Lombardo Ilise 4
4 · Axovant Sciences Ltd. · Filed Aug 17, 2018
Insider Transaction Report
Form 4
Lombardo Ilise
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-08-15+100,000→ 100,000 totalExercise: $2.02Exp: 2028-08-14→ Common Shares (100,000 underlying)
Footnotes (2)
- [F1]One-third of the option will vest at such time as the Issuer's stock price is equal to $6.06; one-third of the option will vest at such time as the Issuer's stock price is equal to $10.10; and one-third of the option will vest at such time as the Issuer's stock price is equal to $14.14, in each case subject to the Reporting Person providing continuous service to the Issuer on each such date.
- [F2]The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan.